Status:
ACTIVE_NOT_RECRUITING
GLP-1 and Hypoglycemia
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-45 years
Phase:
EARLY_PHASE1
Brief Summary
Low blood sugar can negatively affect how blood vessels function, and this can lead to an increase in the risk for heart attacks, strokes and other problems related to the stiffening and blockage of b...
Eligibility Criteria
Inclusion
- 14 (7 males, 7 females) healthy controls age 30-60 yr.
- 14 (7 males, 7 females) people with type 2 DM age 30-60 yr.
- For type 2 DM: HbA1c 6-10.0%
- No significant diabetic tissue complications (i.e. history of retinopathy, neuropathy, stasis ulcers, etc.)
- Body mass index \>25kg • m-2
Exclusion
- \-
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT01858896
Start Date
July 1 2013
End Date
December 1 2026
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland, Baltimore
Baltimore, Maryland, United States, 21201